Abstract Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body mass index, and adverse cardiovascular events
It's a comprehensive wellness operating system that structures accountability, empowers individual agency, and supports daily habits through remote accessibility
Patients seeking the FDA-approved Zepbound OSA indication specifically
Accure and AviClear Programs: Laser Treatment Options for Acne Care The 1726 nm laser technology, available through Accure and AviClear programs, helps regulate overactive sebaceous glands, which contribute to excess oil production and acne formation
Professor of Medicine, Head of Diabetes Centre, Institute for Clinical and Experimental Medicine
In fact, obesity is not only a feature, but also a disease